Immunogenicity and Safety of DTP-HB-Hib Using New Hepatitis B Bulk (Bio Farma)

Clinical trial NCT05482282 · WITHDRAWN

Trial details

NCT number: NCT05482282
Sponsor: PT Bio Farma
Status: WITHDRAWN
Phase: Phase 3
Study type: INTERVENTIONAL

Diphtheria Vaccine Adverse Reaction Tetanus Vaccine Adverse Reaction Pertussis Vaccine Adverse Reaction Haemophilus Influenzae Type B Vaccine Adverse Reaction Hepatitis B Vaccine Adverse Reaction

Start date: 2025-12-01
Primary completion: 2026-12-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.